With New Leadership, Roche Goes Back To Basics At ASCO

In a time of internal transition, Roche emphasized its deep roots and broad pipeline at its annual event alongside the American Society for Clinical Oncology meeting.

Cancer cells on scientific background.3d illustration

In the absence of a major new molecule coming forward or franchise expansion, Roche's analyst event at the American Society for Clinical Oncology annual meeting fell back on perennial themes, emphasizing the depth and breadth of its oncology business during its portfolio review – with no shortage of superlatives.

The back-to-basics focus on franchise management may reflect Roche’s current time of transition. Chief executive officer Bill Anderson took the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from ASCO

More from Conferences